ArticleTherapeutic advances in drug safety2026

Integration of pre‑existing cardiovascular comorbidity into CDK4/6 inhibitor selection for breast cancer.

Chanhyun Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.